BackSatellos Bioscience Overview

Satellos Bioscience Receivables

Latest receivables for MSCL.V: $920K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$917090.00
↑ 347.36% YoYΔ $712090.00 vs prior year quarter

Peer trimmed avg / median

Loading

Satellos Bioscience Receivables History

Loading

Satellos Bioscience vs. peers: Receivables Comparison

Loading

Satellos Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Satellos Bioscience (MSCL.V) FAQ

Satellos Bioscience's receivables stands at $920K as of September 2026. That compares with $210K in the prior-year period — up 347.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Satellos Bioscience reported $920K in receivables versus $210K a year earlier — a 347.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $210K in the prior-year period — up 347.4% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Satellos Bioscience's receivables evolved across reporting periods, while the comparison chart places MSCL.V next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.